Elevra Lithium Ltd
ELVR Nasdaq Mining & Quarrying Of Nonmetallic Minerals (No Fuels) Financials FY2023–FY2025
What Elevra Lithium Ltd does
No business description yet.
- Legal name
- Elevra Lithium Ltd
- Fiscal year ends
- June 30, 2025
- Latest annual report
- 20-F · Oct 31, 2025
- Accession · CIK
- 0001140361-25-040022
0001739016
Revenue and margins
Elevra Lithium Ltd had $145M of revenue in fiscal 2025, up 9.8% on the year before.
Net income and earnings per share
Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was −$22.3M in fiscal 2025, −15.4% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Elevra Lithium Ltd returned — to shareholders in fiscal 2025. The diluted share count rose 7.5%.
Balance sheet
Cash, debt and the ratios that show how comfortably Elevra Lithium Ltd can carry it.
| Fiscal year end | FY23 | FY24 | FY25 |
|---|---|---|---|
| Cash and short-term investments | $140M | $60.3M | $47.2M |
| Debt incl. finance leases | — | $20.4M | $50.6M |
| Debt / equity | — | 0.0x | 0.2x |
| Interest coverage | −14.3x | −29.4x | −78.7x |
| Current ratio | — | 2.5x | 1.4x |
| Quick ratio | — | 1.6x | 1.0x |
| Total assets | $669M | $629M | $426M |
| Total liabilities | $90.2M | $99.5M | $116M |
| Shareholders' equity | $579M | $443M | $274M |
| Net debt (− = net cash) | — | −$39.9M | $3.4M |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. “Plan” marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
—
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8–9 is strong, 0–2 weak.
| Test | FY23 | FY24 | FY25 |
|---|---|---|---|
| Net income is positive | ✕ | ✕ | ✕ |
| Cash from operations is positive | ✕ | ✕ | ✕ |
| Return on assets rose | — | ✕ | ✕ |
| Cash from operations exceeds net income | ✕ | ✓ | ✓ |
| Debt fell relative to assets | — | — | ✕ |
| Current ratio rose | — | — | ✕ |
| Share count didn't rise | — | ✕ | ✕ |
| Gross margin rose | — | — | — |
| Revenue rose relative to assets | — | ✓ | ✓ |
| F-score | — / 3 | — / 6 | 2 / 8 |
| Accruals ratio | 3.5% | −4.0% | −34.3% |
| Altman Z'' | — | 4.33 | −3.05 |
3 years of figures
Amounts in USD. Hover a ratio’s name for its definition.
| Fiscal year | FY23 | FY24 | FY25 |
|---|---|---|---|
| Income statement | |||
| Revenue | $0.0M | $132M | $145M |
| Operating income | −$14.5M | −$78.0M | −$249M |
| Interest expense | $1.0M | $2.7M | $3.2M |
| Pretax income | −$4.5M | −$75.7M | −$249M |
| Income tax | $2.5M | $2.3M | −$1.9M |
| Net income | −$7.4M | −$66.5M | −$190M |
| Net income to common | −$7.4M | −$66.5M | −$190M |
| Diluted EPS | −$1.31 | −$9.94 | −$26.51 |
| Diluted shares | 0.01B | 0.01B | 0.01B |
| Cash flow | |||
| Cash from operations | −$31.0M | −$40.8M | −$9.6M |
| Capital expenditure | $85.5M | $67.2M | $12.7M |
| Free cash flow | −$116M | −$108M | −$22.3M |
| Depreciation and amortization | $4.1M | $22.1M | $25.0M |
| Stock-based compensation | $2.9M | −$0.2M | $1.7M |
| Balance sheet | |||
| Cash and short-term investments | $140M | $60.3M | $47.2M |
| Total debt | — | $20.4M | $50.6M |
| Current assets | — | $145M | $106M |
| Current liabilities | — | $58.8M | $77.4M |
| Inventory | — | $48.6M | $30.9M |
| Property and equipment, net | — | $484M | $312M |
| Total assets | $669M | $629M | $426M |
| Total liabilities | $90.2M | $99.5M | $116M |
| Shareholders' equity | $579M | $443M | $274M |
| Margins | |||
| Operating margin | — | −59.3% | −172.1% |
| EBITDA margin | — | −42.5% | −154.8% |
| Net margin | — | −50.5% | −131.8% |
| FCF margin | — | −82.0% | −15.4% |
| Returns | |||
| Return on capital | — | −15.3% | −70.7% |
| Return on capital employed | — | −13.7% | −71.3% |
| Return on equity | −1.3% | −13.0% | −53.1% |
| Return on assets | −1.1% | −10.2% | −36.1% |
| Return on tangible equity | −1.3% | −15.0% | −69.4% |
| Growth | |||
| Revenue growth | — | — | 9.8% |
| Share count change | — | 18.2% | 7.5% |
| Financial health | |||
| Debt / equity | — | 0.0x | 0.2x |
| Interest coverage | −14.3x | −29.4x | −78.7x |
| Current ratio | — | 2.5x | 1.4x |
| Quick ratio | — | 1.6x | 1.0x |
| Capital allocation | |||
| Capex / revenue | — | 51.0% | 8.8% |
| Stock comp / revenue | — | −0.1% | 1.2% |
| Quality scores | |||
| Piotroski F-score | — | — | 2.0 |
| Altman Z'' | — | 4.3 | −3.0 |
| Accruals ratio | 3.5% | −4.0% | −34.3% |
Source: SEC EDGAR XBRL filings (CIK 0001739016). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. Filed in AUD under IFRS and converted to US$: income and cash-flow lines at each period's average exchange rate, balance-sheet lines at the period-end rate. Per-share figures are per US-listed share (1 ADS = 10 ordinary shares). For information only — not investment advice. Check the original filings before relying on any figure.